Aratana Therapeutics (PETX) Tops Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. GOOGL
3. MSFT
4. AMZN
5. INTC
6. FTNT
7. EBAY
8. DASH
9. CMG
10. CART

Go back to Aratana Therapeutics (PETX) Tops Q3 EPS by 3c

Aratana Therapeutics Reports Third Quarter 2015 Results

November 5, 2015 5:01 PM EST

KANSAS CITY, Kan., Nov. 5, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, announced its third quarter 2015 financial and operational results. For the quarter ended September 30, 2015, Aratana reported a net loss of $54.4 million or $1.58 basic loss per share. Results included a non-cash asset impairment charge of $43.4 million or $1.26 per share.

"Our portfolio of pet therapeutics continues to move through the regulatory process and if successful, we expect to bring an unprecedented number of innovative... More